Four promoters of Lyka Labs Limited bought 55,967 shares for ₹39 lakh at ₹69.85 apiece, increasing their holding from 57,01,000 to 57,56,967 shares through the open market.
A pharmaceutical manufacturer engaged in developing, producing, and marketing finished dosage formulations across multiple therapeutic areas. Incorporated in 1976, the company focuses on quality manufacturing and distribution of pharmaceutical products to meet domestic healthcare needs. Lyka Labs operates as a vertically integrated player in India's pharmaceutical sector, serving patients and healthcare providers through its diversified portfolio of generic and branded medications across various treatment segments.
